Femillex® (Femilex®)

Femillex®
Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceLactic acidLactic acid
Similar drugsTo uncover
  • Femillex®
    suppositories the vagina. 
    NIZHFARM, JSC     Russia
    • Dosage form: & nbspSuppositories are vaginal.
    Composition:One vaginal suppository contains: active substance - lactic acid - 100 mg (in terms of 100% substance); the basis for suppositories is sufficient to obtain a suppository with a weight of 3.0 g: macrogol - 1500 (polyethylene oxide - 1500) - 92-98%, macrogol - 400 (polyethylene oxide - 400) - 8-2%.
    Description:

    Suppositories white or white with a yellowish hue of color, torpedo-shaped. Marble surface is allowed.

    Pharmacotherapeutic group:Antiseptic
    ATX: & nbsp

    G.01.A.D.01   Lactic acid

    G.01.A.D   Organic acids

    Pharmacodynamics:

    Lactic acid is a natural product of the vital activity of lactic acid bacteria of the vagina, provides a pH of the vaginal secretion in the range of 3.5-4.5. Suppositories with lactic acid help restore and maintain normal pH and flora of the vagina, suppress the growth of acid-sensitive pathogenic and conditionally pathogenic flora.

    Lactic acid creates an acid reserve to correct the shift of pH observed in vaginal infections to the alkaline side. Promotes increased natural protection of the vagina from genital infections.

    Pharmacokinetics:

    There is no information on pharmacokinetics.

    Indications:

    Normalization of impaired microflora and pH of the vagina, including bacterial vaginosis (as part of complex therapy).

    Contraindications:

    Hypersensitivity to the components of the drug, candidiasis vulvovaginitis, pregnancy and the period of breastfeeding, children's age (under 18 years).

    Pregnancy and lactation:The use during pregnancy and during breast-feeding is contraindicated, as clinical studies in pregnant women have not been conducted. There is no information on the penetration into breast milk.
    Dosing and Administration:

    Intravaginal. Before the use of the suppository is released from the contoured package. One vaginal suppository is inserted into the vagina (lying on the back with slightly bent legs) once a day. The course of treatment is 10 days.

    Side effects:There may be allergic reactions, itching, in rare cases - burning in the vagina, after the drug is withdrawn.
    Overdose:

    No cases of drug overdose have been reported.

    Interaction:There is no information.
    Special instructions:If burning and itching occurs, it is recommended that a check be done to exclude the fungal infection of the vagina.
    Form release / dosage:Vaginal suppositories 100 mg.
    Packaging:

    5 suppositories are placed in a contiguous packing. One or two contour packs together with instructions for medical use of the drug are placed in a pack of cardboard.

    Storage conditions:

    At a temperature of no higher than 25 ° C.

    Keep out of the reach of children.
    Shelf life:2 years. Do not use after expiry date.
    Terms of leave from pharmacies:Without recipe
    Registration number:LP-001689
    Date of registration:03.05.2012
    The owner of the registration certificate:NIZHFARM, JSC NIZHFARM, JSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp20.10.2015
    Illustrated instructions
      Instructions
      Up